RenovoRx (RNXT) Stock Forecast for 2023 – 2026. Sell or Buy?
Updated: December 5, 2023 (10:51)Sector: Healthcare
The share price of RenovoRx, Inc. (RNXT) now
50/200 Day Moving Average: $1.018 / $2.132
This figure corresponds to the Average Price over the previous 50/200 days. For RenovoRx stocks, the 50-day moving average is the resistance level today.
For RenovoRx stocks, the 200-day moving average is the resistance level today.
Are you interested in RenovoRx, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the RenovoRx stock price in 2024, 2025, 2026, 2027, 2028. How much will one RenovoRx share be worth in 2024 - 2028?
When should I take profit in RenovoRx stock? When should I record a loss on RenovoRx stock? What are analysts' forecasts for RenovoRx stock? What is the future of RenovoRx stock? We forecast RenovoRx stock performance using neural networks based on historical data on RenovoRx stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
RenovoRx stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for RenovoRx shares. This happens once a day.
Historical and forecast chart of RenovoRx stock
The chart below shows the historical price of RenovoRx stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the RenovoRx stock price can be found in the table below.
Long-term forecasts by years.
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for the local treatment of solid tumors. Its therapy platform, RenovoRx, handles the optimizing drug concentration in solid tumors using approved small molecule chemotherapeutics that enable physicians to isolate segments of the vascular anatomy closest to tumors and force chemotherapy across the blood vessel wall to bathe these difficult-to-reach tumors in chemotherapy. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.
RenovoRx daily forecast for a month
RenovoRx Daily Price Targets
RenovoRx Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $0.65.
Negative dynamics for RenovoRx shares will prevail with possible volatility of 10.690%.
Pessimistic target level: 0.61
Optimistic target level: 0.69
RenovoRx Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $0.65.
Positive dynamics for RenovoRx shares will prevail with possible volatility of 8.940%.
Pessimistic target level: 0.61
Optimistic target level: 0.67
RenovoRx Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $0.69.
Positive dynamics for RenovoRx shares will prevail with possible volatility of 9.766%.
Pessimistic target level: 0.65
Optimistic target level: 0.72
RenovoRx Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $0.72.
Positive dynamics for RenovoRx shares will prevail with possible volatility of 12.437%.
Pessimistic target level: 0.65
Optimistic target level: 0.74
RenovoRx Stock Forecast 12-11-2023.
Forecast target price for 12-11-2023: $0.80.
Positive dynamics for RenovoRx shares will prevail with possible volatility of 14.923%.
Pessimistic target level: 0.75
Optimistic target level: 0.88
RenovoRx Stock Forecast 12-12-2023.
Forecast target price for 12-12-2023: $0.86.
Positive dynamics for RenovoRx shares will prevail with possible volatility of 13.450%.
Pessimistic target level: 0.78
Optimistic target level: 0.90
RNXT (RNXT) Monthly Stock Prediction for 2024
RenovoRx forecast for this year
RenovoRx Stock Prediction for Jan 2024
An uptrend is forecast for this month with an optimal target price of $0.7267. Pessimistic: $0.64. Optimistic: $0.77
RenovoRx Stock Prediction for Feb 2024
An uptrend is forecast for this month with an optimal target price of $0.79065. Pessimistic: $0.67. Optimistic: $0.89
RenovoRx Stock Prediction for Mar 2024
An downtrend is forecast for this month with an optimal target price of $0.76693. Pessimistic: $0.69. Optimistic: $0.85
RenovoRx Stock Prediction for Apr 2024
An downtrend is forecast for this month with an optimal target price of $0.638086. Pessimistic: $0.57. Optimistic: $0.72
RenovoRx Stock Prediction for May 2024
An uptrend is forecast for this month with an optimal target price of $0.647019. Pessimistic: $0.55. Optimistic: $0.70
RenovoRx Stock Prediction for Jun 2024
An uptrend is forecast for this month with an optimal target price of $0.680664. Pessimistic: $0.65. Optimistic: $0.71
RenovoRx Stock Prediction for Jul 2024
An uptrend is forecast for this month with an optimal target price of $0.692916. Pessimistic: $0.59. Optimistic: $0.79
RenovoRx Stock Prediction for Aug 2024
An uptrend is forecast for this month with an optimal target price of $0.704003. Pessimistic: $0.63. Optimistic: $0.80
RenovoRx Stock Prediction for Sep 2024
An uptrend is forecast for this month with an optimal target price of $0.756099. Pessimistic: $0.66. Optimistic: $0.79
RenovoRx Stock Prediction for Oct 2024
An downtrend is forecast for this month with an optimal target price of $0.695611. Pessimistic: $0.62. Optimistic: $0.73
RenovoRx Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $0.71787. Pessimistic: $0.61. Optimistic: $0.79
RenovoRx Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $0.68772. Pessimistic: $0.63. Optimistic: $0.75
RenovoRx (RNXT) Monthly Stock Prediction for 2025
RenovoRx (RNXT) Monthly Stock Prediction for 2026
RenovoRx (RNXT) Monthly Stock Prediction for 2027
RenovoRx (RNXT) Monthly Stock Prediction for 2028
RenovoRx information and performance
333 W. SANTA CLARA STREET, SUITE 900, SAN JOSE, CA, US
Market capitalization of the RenovoRx, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of RNXT shares in the company outstanding by the market price of one share.
EBITDA of RenovoRx is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.